pharma · Breast Neoplasms · Radiation Injuries
Sun Yat-sen Memorial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial is a pharma organization headquartered in CN. Primary therapeutic focus areas include Breast Neoplasms, Radiation Injuries, Breast Cancer, Platinum-resistant Recurrent Clear Cell Ovarian Cancer, Brea
Guangzhou, CN HQ
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Employees
- 32
- Programs
- 7
- Drugs
- 16
- Patents
- 0
Niraparib
Phase 2 · small molecule · Platinum-resistant Recurrent Clear Cell Ovarian Cancer
Niraparib for Platinum-resistant Recurrent Clear Cell Ovarian Cancer is a Phase 2 program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).
Internal code 2021-KY-016
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Platinum-resistant Recurrent Clear Cell Ovarian Cancer
- Status
- completed
- Trials
- 1